Australia Facial Injectable Market Size, Share & Trends Analysis Report By Product (Hyaluronic Acid, Botulinum Toxin Type A), By Application (Aesthetics, Therapeutics), And Segment Forecast, 2023 - 2030

Report Overview

The Australia facial injectable market size was valued at USD 3.5 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 27.3% from 2023 to 2030. Facial injectables have become extremely popular and widely accepted. Due to the growing acceptance and use of injectable cosmeceutical products by baby boomers in recent decades, there is a rising desire for non-surgical aesthetic enhancement. Facial injectables are crucial in anti-aging treatments and are particularly used to stop damage like hyperpigmentation and early aging. The most often used injectables are substances like Botox and fillers. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Its demand in the cosmetics business is being driven by its ease of use, transient nature, and affordability in comparison to other areas. The cosmetic market has been shaped by changing customer demands. Since the majority of consumers are nowadays highly influenced by social media, there has been an increase in public awareness about anti-aging products. Therefore, offering cutting-edge and efficient products and services has become crucial for industry participants. One of the major industry drivers is the rising demand for anti-aging skin care products. As the millennial generation becomes older, the demand will continue to rise. Numerous methods and services for aesthetic enhancement have emerged as a result of technological advancements in the beauty sector.

Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic. The outbreak first had a negative impact on the facial injectable business but eventually saw an increase in botulinum toxin sales. Over 6 million surgeries or treatments including cosmetic Botox are carried out annually, a 700% increase in just the last 20 years. During the COVID-19 pandemic, the demand for aesthetic procedures, such as Botox and fillers, had significantly surged.

Product Insights

On the basis of products, the industry has been further categorized into Hyaluronic Acid (HA), botulinum toxin type A, Calcium Hydroxylapatite (CaHA), and polymer fillers. The botulinum toxin type A product segment dominated the industry in 2022 and accounted for the maximum share of more than 54.9% of the overall revenue. On account of its potent water retention capabilities and thorough penetration of the epidermis, the demand for dermal filler is increasing. The botulinum toxin type A segment is anticipated to expand further at a significant growth rate during the forecast period.

This growth can be attributed to the increasing usage of BoNTA in cosmetics (aesthetics), for enhancing the facial look and minimizing the indications of aging. Cosmetic-grade HA’s low molecular weight makes it easier for the substance to penetrate deeply into the epidermis, aiding in the retention of water in the cells and the release of antioxidants that slow down the aging process. Hyaluronic acid works as a moisturizer and supports in the healing of burns, skin ulcers, and wounds. In plastic surgery, it is also applied as a lip filler. The segment is anticipated to grow at the fastest CAGR during the forecast period as a result of an increase in the usage of HA as a dermal filler or in cosmetic injectables.

Application Insights

On the basis of applications, the industry has been further categorized intoaesthetics and therapeutics. On account of the rising spending on aesthetic procedures and the growing consumer awareness regarding these procedures, the aesthetics application segment dominated the overall industry in 2022. The segment accounted for the maximum share of more than 71% of the overall revenue in the same year. As a result of the increasing awareness about aesthetic operations and rising consumer disposable income levels, the aesthetics segment is anticipated to expand further at the fastest growth rate during the forecast period.

Market expansion is augmented by a rise in the usage of cosmetic injectables for facial wrinkles, parentheses lines, lip lines, lip augmentation, lip border repair, and crow’s feet lines. The therapeutic segment is also anticipated to register a significant growth rate during the forecast period. The increasing usage of facial injectables in the treatment of strabismus or crossed eyes, blepharospasm, Meige’s syndrome, hemifacial Spasms (HFS), Oromandibular Dystonia (OMD), and focal hyperhidrosis is increasing the demand for therapeutics, thereby supporting the segment growth.

Key Companies & Market Share Insights

The market is highly competitive and tightly controlled. The major industry players have developed crucial business strategies, including product innovations, partnerships & collaborations, new product launches, joint ventures, contracts, and advanced service launches, to establish their industry position and acquire a sizable portion of the revenue. To get a foothold in the industry, the players therein engage in numerous strategic alliances. For instance, in June 2021, SILK Laser Australia Ltd. signed a contract to buy Beauty Services Holdings Pty. Ltd. Some of the prominent players in the Australia facial injectable market include:

• SILK Laser Clinics

• Advanced Clinics Australia

• Results Laser Clinic

• Australian Skin Clinics

• Laser Clinics Australia

Australia Facial Injectable Market Report Scope

Australia Facial Injectable Market Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the Australia facial injectable market report on the basis of product and application:

• Product Outlook, (Revenue, USD Billion, 2018 - 2030)

  • Collagen

  • Hyaluronic Acid (HA)

  • Botulinum Toxin Type A

  • Calcium Hydroxylapatite (CaHA)

  • Polymer Fillers

    • Polymethylmethacrylate Microspheres (PMMA)

    • PLLA (Poly-L-lactic acid)

• Application Outlook, (Revenue, USD Billion, 2018 - 2030)

  • Aesthetics

  • Therapeutics